how many americans are taking glp 1 Gallup | More using GLP-1 medications for weight loss than ever before. Gallup finds that 11% of U.S. adults currently take a GLP-1 Insurance coverage just changed for

Dual and Triple Agonists: The next generation of medications, such as Tirzepatide (which targets both GLP-1 and GIP receptors), are already demonstrating even greater efficacy for weight loss and blood sugar control

For autoimmune patients already at risk for bone loss, this could be a clinically meaningful distinction when choosing between available GLP-1/GIP medications

Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, et al

Diabetes and Cataracts Diabetes is a chronic disease that affects about 30 million people or over 9 percent of the population in the United States

Weight regain typically begins within 1-3 months of discontinuation, with most patients regaining 50-75% of their lost weight within one year